Experimental agent reduces breast cancer metastasis to bone
Wednesday, November 4, 2009 - 07:21
in Health & Medicine
Researchers have reduced breast cancer metastasis to bone using an experimental agent to inhibit ROCK, a protein that was found to be over-expressed in metastatic breast cancer. In a study in mice, the team of researchers from Tufts University School of Medicine, the Sackler School of Graduate Biomedical Sciences at Tufts, and Tufts Medical Centre report that inhibiting ROCK, or Rho-associated kinase, in the earliest stages of breast cancer decreased metastatic tumour mass in bone by 77 percent and overall frequency of metastasis by 36 percent. The results suggest that ROCK may be a target for new drug therapies to reduce breast cancer metastasis...
Read the whole article on Science Centric
More from Science Centric
Related
- Experimental agent reduces breast cancer metastasis to boneTue, 3 Nov 2009, 13:51:31 EST
- New test may predict breast cancer metastasisFri, 27 Mar 2009, 15:29:09 EDT
- RNA snippet suppresses spread of aggressive breast cancerMon, 15 Jun 2009, 17:50:50 EDT
- Targeting MMPs to halt advanced metastatic breast cancerThu, 16 Jul 2009, 12:30:42 EDT
- Jefferson researchers show antibody to breast cancer-secreted protein blocks metastasisTue, 8 Jul 2008, 10:28:50 EDT